Oaktree Acquisition Corp. III Life Sciences: preliminary redemption results

What happened Oaktree Acquisition Corp. III Life Sciences filed an 8-K dated Oct 15, 2026 reporting preliminary redemption results tied to an Extension Proxy Statement it filed on Oct 2, 2026 for an extraordinary general meeting to be held on Oct 16, 2026 to consider a proposal to extend the date to complete an initial business combination. The filing reports that 13,326,977 Class A ordinary shares were tendered for redemption prior to the Redemption Deadline of 5:00 p.m., Eastern Time, on Oct 14, 2026. The Sponsor intends to convert 4,798,758 Class B ordinary shares into 4,798,758 Class A ordinary shares on a one-for-one basis; assuming the stated redemptions and the Conversion, OAC will have 11,254,791 Class A ordinary shares and 1,000 Class B ordinary shares issued and outstanding.

Key details

• Redemption deadline: 5:00 p.m., Eastern Time, on Oct 14, 2026; shares tendered for redemption: 13,326,977 Class A ordinary shares.
• Sponsor conversion: Sponsor intends to convert 4,798,758 Class B ordinary shares into 4,798,758 Class A ordinary shares pursuant to Article 14 of the memorandum and articles of association.
• Post-conversion holdings: Sponsor will hold 5,382,739 Class A ordinary shares (including 583,981 private placement shares) and 1,000 Class B ordinary shares.
• Mechanics and restrictions: Conversion will be effected by repurchase of Class B shares and application of repurchase proceeds to pay up Class A at par; the converted Class A shares will remain Founder Shares, not Public Shares, subject to transfer restrictions, waiver of redemption rights, and the obligation to vote in favor of a business combination.
• Withdrawal contact: shareholders may request withdrawal of redemption by contacting Continental Stock Transfer & Trust Company at spacredemptions@continentalstock.com.

Why it may matter This report was filed under Item 7.01, Regulation FD Disclosure, and covers preliminary shareholder redemptions and a planned sponsor conversion related to OAC’s request to extend the deadline to complete a business combination. This filing does not show why the insider traded or why the company acted.